A Phase 2 Study of Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (S50.004)

Journal article

Peer reviewed

Michael Weiss, Zachary Simmons, Nazem Atassi, Michael Graves, Nicholas Parziale, Johnny Salameh, Colin Quinn, Robert Brown, B Distad, Jaya Trivedi, …

Neurology, Vol.84(14_supplement)

04/06/2015

Metrics

1 Record Views

Title: A Phase 2 Study of Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (S50.004)
Creators: Michael Weiss - University of Washington Medical Center
Zachary Simmons - Penn State Milton S. Hershey Medical Center
Nazem Atassi - Massachusetts General Hospital
Michael Graves - Pacific Palisades CA United States
Nicholas Parziale - UCLA Health
Johnny Salameh - Massachusetts Academy of Math and Science at WPI
Colin Quinn - University of Massachusetts Chan Medical School
Robert Brown - University of Massachusetts Chan Medical School
B Distad - University of Washington
Jaya Trivedi - Dallas TX United States
Jeremy Shefner - SUNY Upstate Medical University
et al.
Publication Details: Neurology, Vol.84(14_supplement)
Identifiers: 991006262270802656
Academic Unit: Neurology
Language: English
Resource Type: Journal article